With no winners (yet) in the competition among cannabis MSO's, here are a few facts and suggestions on where investors should be looking
Marijuana Investing
Tilray® Expands European Leadership Team announcing Five Senior Appointments
Tilray expands management team of its European division with five new appointments
Federal Minister Rejects Ontario’s Claim of “Pot Shortage”
cannabis, marijuana stocks, stocks
Nutritional High's Partner Obtains Provisional California Distribution License
Nutritional High's Southern California partner receives one-year provisional distribution license for Sacramento facility
MSO’s Prominent Among 500 Applicants for Missouri Cannabis Licenses
U.S. multi-state operators (MSO's) are prominent among more than 500 applicants for 338 medical cannabis licenses in Missouri
Naturally Splendid Launches NATERA(TM) Sport Bars in Major Retailers Across Canada
Naturally Splendid's NATERA(TM) Key-to-Life keto bars are now available on retail store shelves across Canada
Bad Optics: MedMen Co-Founder Buys Extravagant L.A. Mansion
I’ve got some good news or bad news for you depending on where you’re at with cannabis stocks right now.
The END of Cannabis Prohibition? Congress to Schedule Hearing
Media reports indicate that Congress will hold a hearing next week to review cannabis' legal status federally
Is Ontario Government Responsible for Bruce Linton Firing?
Canopy Growth, Canada's largest pot company, has been almost shut out of Canada's single largest market. Today the CEO paid the price.
Canopy Growth Announces Leadership Change
Canopy Growth's co-CEO Bruce Linton has stepped down. Mark Zekulin becomes sole CEO.
Cannex Announces New Milestones With California Expansion Plans
Cannex secures 190,000 square foot facility for expansion into California
Evolving Cannabis Attitudes: 63% of London Residents Want Fully Legal Weed
Pro-cannabis support is increasing around the world with lightning speed. This means MORE new markets, faster than expected. And more revenues.
FSD Pharma Closes Deal to Acquire Prismic Pharmaceuticals
FSD Pharma acquires U.S.-based specialty R&D pharmaceutical company
Blueberries Executes Agreement to Acquire Cannabis Cultivation, Processing & Manufacturing Rights for 3.2M Square Foot Argentina Property
Blueberries Medical Corp enters Argentina cannabis market with major acquisition
1933 Industries Reports $4.6 Million Revenue and Third Quarter Fiscal Year 2019 Financial Results
1933 Industries reports $4.6 million in Q3 revenue along with fiscal and financial results for the quarter